Our Team

Thor Ostenfeld M.B.Ch.B, Ph.D

Director, Experimental Medicine

Thor Ostenfeld joined the ceedd in November 2010 as Director of Experimental Medicine. He carries responsibilities for managing Investigational Medicine and Clinical Drug Discovery to proof-of-concept (POC) within the ceedd collaborations and alliances. He has 20 years of experience gained in the UK health service as a practicing clinician, academic research and in the pharmaceutical industry. Thor has been part of GlaxoSmithKline R&D Drug Discovery for nine years and brings a wealth of clinical development and project leadership experience from the neurosciences portfolio. He studied pharmacology and medicine at the University of Dundee prior to specialisation in anaesthesia & critical care, and gained his Ph.D. in stem cell neurobiology at Cambridge University.

Thor Ostenfeld M.B.Ch.B, Ph.D

At GlaxoSmithKline (GSK) a specialized R&D unit is driving growth in external drug discovery to complement the late-stage GSK pipeline.The Center of Excellence for External Drug Discovery (ceedd) builds and personally manages unique risk/reward-sharing drug discovery alliances with world class biotech companies. We work directly with these companies to bring programs from target to clinical proof of concept, at which stage GSK has options to license for full development and commercialization. As a small, multidisciplinary team, we share our alliance companies’ entrepreneurial spirit and agility, and complement their capabilities with broad expertise and access to big pharma resources to bring innovative new medicines to more patients more quickly.

Read More ››

United States

2301 Renaissance Boulevard
P.O. Box 61540
King of Prussia, PA 19406-2772 (USA)

Directions ››   Map ››
Email US

United Kingdom

Gunnels Wood Road
Stevenage
Hertfordshire SG1 2NY (UK)

Directions ››   Map ››
Email UK

Privacy  |   Terms  |   Sitemap  
© 2009 ceedd